HTP

H.I.G. Technology Partners Makes a Strategic Investment in Mobileum

Retrieved on: 
Monday, January 31, 2022
Telecommunications, Networks, Finance, Banking, Data Management, Professional Services, Technology, Mobile, Wireless, CLO, Growth, CEO, Telecom, Fraud, Cambridge Technology Partners, Silicon, Kirkland & Ellis, Audax, Intelligence, H.I.G. Capital, BDC, Technology, Risk management, United Arab Emirates, Partnership, Company, LLP, IOT, Investment, Solution, HTP, CA, Whitehorse, Bank, Financial services

Technology Partners (HTP) has entered into a definitive agreement to make a strategic investment in Mobileum, Inc. (Mobileum or the Company) to help the Company accelerate technology investments and growth enabled by the roll-out of 5G technologies and private networks across the world.

Key Points: 
  • Technology Partners (HTP) has entered into a definitive agreement to make a strategic investment in Mobileum, Inc. (Mobileum or the Company) to help the Company accelerate technology investments and growth enabled by the roll-out of 5G technologies and private networks across the world.
  • will be the majority owner of Mobileum alongside previous owner Audax, which will retain a minority stake.
  • We are excited to partner with Bobby, the Mobileum team, and Audax to accelerate technology investments and continue growing with our telco partners.
  • Technology Partners commented: We are delighted to invest in Mobileum.

WorkWave's Beyond Service User Conference Brings Together the WorkWave Family of Brands for the First Time

Retrieved on: 
Wednesday, January 19, 2022
Cloud, HTP, Technology, Team software process, Conference, Stevie Awards, Beyond, CEO, Learning, Solution, Software, Slingshot, Q&A, HVAC, NFL, Industry, Marketing, Year, Software as a service, Pest control, Odisha Living Legend Award, Video game, Online shopping

This impactful new event delivered valuable business insights, networking opportunities and exciting entertainment to WorkWave's pest control, lawn care and HVAC customers.

Key Points: 
  • This impactful new event delivered valuable business insights, networking opportunities and exciting entertainment to WorkWave's pest control, lawn care and HVAC customers.
  • The 2022 Beyond Service User Conference, held in Orlando, Florida, on Jan. 9-12, offered a powerful reimagining of three leading field service events, as they came together as one: the WorkWave User Conference, Real Green's Solutions Users Conference, and Coalmarch's CO2 Conference.
  • The combined event reflects the unprecedented consolidation of market-leading field service software solutions WorkWave, Real Green, Coalmarch, Slingshot, Lawnbot, and most recently TEAM Software, under the WorkWave brand.
  • In addition, WorkWave recognized its outstanding customers for exceptional service and performance with a variety of awards.

HTG Molecular Diagnostics Announces Certain Preliminary 2021 Unaudited Financial Results

Retrieved on: 
Thursday, January 6, 2022
COVID-19, Drug discovery, Growth, Therapy, Mission statement, Publication, Private Securities Litigation Reform Act, CEO, SEC, Precision medicine, HTG, HTP, RNA, Diagnosis, GLOBE, Risk, Nasdaq, Industry, U.S. Securities and Exchange Commission, Cryptocurrency, Medical device, Pharmaceutical industry

TUCSON, Ariz., Jan. 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced certain preliminary, unaudited financial results for the year ended December 31, 2021.

Key Points: 
  • Cash, cash equivalents and short-term marketable securities of $21.9 million as of December 31, 2021
    TUCSON, Ariz., Jan. 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced certain preliminary, unaudited financial results for the year ended December 31, 2021.
  • Total revenue for the full year 2021 is expected to be approximately $8.9 million, including approximately $1.4 million of HTG Transcriptome Panel (HTP) revenue.
  • Actual results may differ materially from these preliminary unaudited results as a result of the completion of year-end closing procedures, final adjustments and other developments arising between now and the time that companys financial results are finalized, and such changes could be material.
  • The company expects to announce full 2021 financial results in advance of its quarterly conference call in March 2022.

HTG Completes HTP Product Next-Phase Development Milestone

Retrieved on: 
Wednesday, December 22, 2021
HTG, Precision medicine, U.S. Securities and Exchange Commission, RNA, Nasdaq, Risk, Drug discovery, Private Securities Litigation Reform Act, Degenerative disease, Efficiency, HTP, Gene expression profiling, Method, Industry, Achievement, Senior, Diagnosis, SEC, Therapy, COVID-19, Infection, White, RNA-Seq, GLOBE, Biomarker, HP, Fine chemical

TUCSON, Ariz., Dec. 22, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has now expanded the potential markets and applications for its pioneering HTG Transcriptome Panel (HTP).

Key Points: 
  • TUCSON, Ariz., Dec. 22, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has now expanded the potential markets and applications for its pioneering HTG Transcriptome Panel (HTP).
  • Initially validated for neoplastic tissue, HTG has now validated HTP for use with normal FFPE tissue and other non-neoplastic tissues.
  • Our initial validation and launch of HTP was primarily focused on neoplastic FFPE tissue samples in oncology.
  • HTG expects to continue to provide additional internal and expected third party validation data for HTP in future periods.

HTG Expands Therapeutics Scientific Advisory Board With Addition of Dr. Jerald Radich

Retrieved on: 
Thursday, December 16, 2021
Fred Hutchinson Cancer Research Center, Therapy, Dasatinib, HTP, U.S. Securities and Exchange Commission, RNA, RNA transfection, FDA, MicroRNA, Diagnosis, Toxicity, Private Securities Litigation Reform Act, Industry, Nasdaq, Media, COVID-19, Methylation, HTG, CML, SEC, Risk, Drug discovery, Research, Goal, Patient, Disease, Nilotinib, Transcriptome, Emergency medical responder levels by U.S. state, Mirna, Leukemia, GLOBE, Senior, Precision medicine, Pharmaceutical industry

TUCSON, Ariz., Dec. 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTGs Therapeutics Scientific Advisory Board.

Key Points: 
  • TUCSON, Ariz., Dec. 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTGs Therapeutics Scientific Advisory Board.
  • Dr. Radich adds to the companys growing group of esteemed advisors as HTG continues to expand its therapeutics division activities targeting disruption of the existing drug discovery process.
  • Dr. Radich brings an extraordinary depth of experience in the fields of cancer diagnostics and therapeutics, as well as research, to understand the basis of response versus non-response to both standard leukemia therapies and more recent molecular targeting approaches, said Stephen Barat, Senior Vice President of Therapeutics at HTG.
  • HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.

Packable and Tradeswell Enter into Partnership to Enhance SaaS Offerings for Clients with Data-Driven, AI-powered Technology

Retrieved on: 
Wednesday, December 15, 2021
Technology, Retail, Other Technology, Other Retail, Forward-looking statement, Software as a service, HTP, Failure, Form, Solution, D2C, SKU, Government, Commerce, Intelligence, Growth, NYSE, Ownership, Private Securities Litigation Reform Act, Sale, SPAC, Acquisition, Annual report, THE, Securities Act of 1933, AI, SEC, LLC, Probability, Risk, CEO, Marketing, Machine learning, DTC, EBay, Efficiency, Multimedia, Target, Kroger, Walmart, Partnership, Person, Acceleration, News, HTPA, Technology, Communication, Prospectus, Online shopping, Retail, Google, Amazon, Facebook

Were also proud to be making an investment in Tradeswell, demonstrating our confidence in the long-term viability of their technology and allowing the Tradeswell team to reach new heights.

Key Points: 
  • Were also proud to be making an investment in Tradeswell, demonstrating our confidence in the long-term viability of their technology and allowing the Tradeswell team to reach new heights.
  • By working with Packable and Tradeswell, brands can rely on the right tools and technology for lightning-fast, machine-smart decision-making.
  • Packable is a powerhouse and sets the industry standard in the markets it serves and each that it enters, said Paul Palmieri, CEO of Tradeswell.
  • On September 9, 2021, Packable announced plans to become a public company in partnership with Highland Transcend Partners I Corp. (NYSE: HTPA).

DISCOUNT TIRE INTRODUCES THE COOPER® DISCOVERER® HTP II™ TIRE WITH REVOLUTIONARY HIGHWAY PERFORMANCE

Retrieved on: 
Thursday, December 9, 2021
2019 Monster Energy NASCAR Cup Series, Discount Tire, Ford Motor Company, Technology, NASCAR, Cooper Tire & Rubber Company, Weather, SUV, Partnership, Treadwell, Mustang, Multimedia, No, HTP, Heavy equipment

SCOTTSDALE, Ariz., Dec. 9, 2021 /PRNewswire/ -- Discount Tire has added the Cooper Discoverer HTP II tire to its extensive lineup of leading tire brands.

Key Points: 
  • SCOTTSDALE, Ariz., Dec. 9, 2021 /PRNewswire/ -- Discount Tire has added the Cooper Discoverer HTP II tire to its extensive lineup of leading tire brands.
  • Developed in partnership with Cooper Tires, the all-season performance tire will be available exclusively at over 1,100 Discount Tire retail locations and online through Discount Tire Direct.
  • The Cooper Discoverer HTP IIdelivers revolutionary highway performance.
  • For more information about the Cooper Discoverer HTP II, visit Discount Tire's website, where you can get a 30% shorter average wait time when you buy and book online.

Infosys Equinox Partners With Packable to Help Amplify Its Direct to Consumer E-commerce Offerings for Its Brand Partners

Retrieved on: 
Thursday, December 9, 2021
Technology, Consulting, Marketing, Transport, Communications, Professional Services, Internet, Logistics, Supply Chain Management, Retail, Online Retail, Risk, SEC, Technology, Failure, NSE, THE, Securities Act of 1933, Annual report, Acquisition, Algorithm, Forward-looking statement, Private Securities Litigation Reform Act, HTPA, Industry, EBay, B2B, Multimedia, Marketing, Ecosystem, HTP, U.S. Securities and Exchange Commission, NYSE, Probability, Company, Prospectus, Growth, Security (finance), Target, Government, Kroger, SPAC, LLC, Person, INFY, BSE, API, B2C, Form, Partnership, Walmart, Time, COVID-19, Ownership, D2C, NASDAQ, Sale, Human, Communication, Online shopping, Sales, Risk management, Packable, Infosys Equinox, Infosys, PACKABLE, INFOSYS EQUINOX, INFOSYS

Packable recently announced a merger with Highland Transcend Partners, setting it on the path to becoming a public company.

Key Points: 
  • Packable recently announced a merger with Highland Transcend Partners, setting it on the path to becoming a public company.
  • Through the partnership with Packable, Infosys will integrate its flagship human-centric digital commerce platform, Infosys Equinox , with Packable IQ (Packables proprietary E-commerce platform).
  • The strategic collaboration will strengthen Packables ability to offer its brand partners an engaging, innovative, and agile Direct to Consumer platform (D2C): D2C-in-a-box.
  • Ash Mehra, Chief Information Officer, Packable, said, At Packable, we are actively deepening our relationships with brand partners of all stripes, from household name consumer product's companies to Digitally Native Brands.

HTG Announces Major Sales Milestone for HTG Transcriptome Panel

Retrieved on: 
Thursday, December 9, 2021
U.S. Securities and Exchange Commission, Risk, Research, GLOBE, Precision medicine, SEC, Technology, Therapy, HTG, Drug discovery, RNA-Seq, Private Securities Litigation Reform Act, Industry, White, Method, Senior, COVID-19, RNA, Diagnosis, Nasdaq, Workflow, HTP, Gene expression profiling, Animal, Fine chemical, Pharmaceutical industry

TUCSON, Ariz., Dec. 09, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has exceeded $1 million of revenue recognized from sales of its HTG Transcriptome Panel (HTP) as of November 30, 2021.

Key Points: 
  • TUCSON, Ariz., Dec. 09, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has exceeded $1 million of revenue recognized from sales of its HTG Transcriptome Panel (HTP) as of November 30, 2021.
  • HTP was launched with commercial availability in the United States and Europe in early August 2021.
  • HTGs panel reduces sample input requirements, is less sensitive to sample age, and provides faster turnaround times than other, currently available methods.
  • HTP has also been shown to have a higher sample success rate than RNA-Seq for gene expression profiling.

Broad Far Reveals Four New Heated Tobacco Flavors at 2021 IECIE eCig Expo in Shenzhen

Retrieved on: 
Wednesday, December 8, 2021
Awareness, Company, Carmine, Research, Smoking, Health, Technology, Sustainable Development Goals, Heated tobacco product, Smoker, Industry, Tobacco industry, Sensation, Adult, Smokeless tobacco, Cohesion (linguistics), HTP, Tobacco

SHENZHEN, China, Dec. 8, 2021 /PRNewswire/ --Broad Far (Hong Kong) Co., Ltd ("Broad Far" or "the Company") recently attended one of the world's most influential e-cig expos, the 2021 IECIE Shenzhen China eCig Expo held from December 6-8, where the company introduced its four new flavors of heated tobacco Beach, Carmine, Coral, and Mahogany to a massive in-person audience of 80,000 international industry professionals.

Key Points: 
  • SHENZHEN, China, Dec. 8, 2021 /PRNewswire/ --Broad Far (Hong Kong) Co., Ltd ("Broad Far" or "the Company") recently attended one of the world's most influential e-cig expos, the 2021 IECIE Shenzhen China eCig Expo held from December 6-8, where the company introduced its four new flavors of heated tobacco Beach, Carmine, Coral, and Mahogany to a massive in-person audience of 80,000 international industry professionals.
  • Broad Far launched two categories of heated tobacco sticks, including the classic series of Brown, Yellow, Blue, Lawn, Green, Ice-storm, as well as the enhanced series of Purple Beach, Carmine, Coral, and Mahogany.
  • The Company plans to launch the 3rd generation of heated tobacco products in Q3 2022 with forward-looking designs.
  • Broad Far Hong Kong is a provider of Heated Tobacco Product (HTP) to major tobacco markets across the globe.